BNP Paribas Financial Markets
RDHL

BNP Paribas Financial Markets’s Redhill Biopharma RDHL Stock Holding History

BNP Paribas Financial Markets’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6
Closed -$907 – 4025
2022
Q4 		$907 Buy
6
+3
+100% +$1.3K ﹤0.01% 3814
2022
Q3 		$1.28K Buy
3
+2
+200% +$1.74K ﹤0.01% 4402
2022
Q2 		$1.07K Buy
+1
New +$1.37K ﹤0.01% 3903

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BNP Paribas Financial Markets's RDHL Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 6 shares — an estimated $907 sold.

BNP Paribas Financial Markets first reported a position in RDHL in Q2 2022 and held it in 3 quarters. The position peaked at $1.28K in Q3 2022. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • BNP Paribas Financial Markets reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 6 Redhill Biopharma shares in Q1 2023, an estimated $907.
  • BNP Paribas Financial Markets first reported a position in Redhill Biopharma in Q2 2022 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Redhill Biopharma position peaked at $1.28K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.